Literature DB >> 21909646

Solute carrier protein family may involve in radiation-induced radioresistance of non-small cell lung cancer.

Li Xie1, Xianrang Song, Jinming Yu, Wei Guo, Ling Wei, Yanli Liu, Xingwu Wang.   

Abstract

PURPOSE: To find new signaling pathways that may be involved in the cellular response to ionizing radiation.
METHODS: Two radioresistant subclones (A549/R and SPCA1/R) derived from lung adenocarcinoma cell lines A549 and SPCA1 were established after eight rounds of sublethal irradiation. The new subclones were tested for radioresistant features using clonogenic assay and apoptosis analysis. The genes expressed differentially were screened with cDNA microarray analysis consisting of 48,000 transcript probes and confirmed by quantitative real-time PCR.
RESULTS: Stable and significant radioresistance was observed in the screened subclones. The microarray analysis showed 65 genes were up-regulated and 141 genes down-regulated in SPCA1/R cells. The up-regulated and down-regulated genes were 708 and 230 in A549/R cells, respectively. Twenty-seven altered genes were consistent in both subclones. Interestingly, members the of human solute carrier (SLC) gene superfamily were among in 27 genes.
CONCLUSIONS: The differentially expressed genes in both cell lines may contribute to their radioresistant phenotype. This extensive list of genes identified in the experiment provides a large body of potentially valuable information for studying the molecular mechanism(s) of radiosensitivity and identification of candidate molecular markers of radiation sensitivity. Thus, to our knowledge, the SLC gene superfamily is the first being reported to involve in acquired radioresistance.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21909646     DOI: 10.1007/s00432-011-1050-9

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  20 in total

1.  Expression and functional characterization of platelet-derived growth factor receptor-like gene.

Authors:  Feng-Jie Guo; Wei-Jia Zhang; Ya-Lin Li; Yan Liu; Yue-Hui Li; Jian Huang; Jia-Jia Wang; Ping-Li Xie; Guan-Cheng Li
Journal:  World J Gastroenterol       Date:  2010-03-28       Impact factor: 5.742

2.  Differential gene expression profiles of radioresistant pancreatic cancer cell lines established by fractionated irradiation.

Authors:  Kazuhiko Ogawa; Tohru Utsunomiya; Koshi Mimori; Fumiaki Tanaka; Naotsugu Haraguchi; Hiroshi Inoue; Sadayuki Murayama; Masaki Mori
Journal:  Int J Oncol       Date:  2006-03       Impact factor: 5.650

3.  Gene expression pattern associated with radiotherapy sensitivity in cervical cancer.

Authors:  Y F Wong; D S Sahota; T H Cheung; K W K Lo; S F Yim; T K H Chung; A M Z Chang; D I Smith
Journal:  Cancer J       Date:  2006 May-Jun       Impact factor: 3.360

4.  Regulation of arginine transport and metabolism by protein kinase Calpha in endothelial cells: stimulation of CAT2 transporters and arginase activity.

Authors:  Rossana Visigalli; Amelia Barilli; Alessandro Parolari; Roberto Sala; Bianca Maria Rotoli; Ovidio Bussolati; Gian C Gazzola; Valeria Dall'Asta
Journal:  J Mol Cell Cardiol       Date:  2010-04-26       Impact factor: 5.000

5.  Role of p16 and p14ARF in radio- and chemosensitivity of malignant gliomas.

Authors:  Matthias Simon; David Voss; Tjoung-Won Park-Simon; Ralph Mahlberg; Gertraud Köster
Journal:  Oncol Rep       Date:  2006-07       Impact factor: 3.906

Review 6.  Combined-modality treatment of solid tumors using radiotherapy and molecular targeted agents.

Authors:  Brigette B Y Ma; Robert G Bristow; John Kim; Lillian L Siu
Journal:  J Clin Oncol       Date:  2003-07-15       Impact factor: 44.544

7.  Phase I study of liposome-encapsulated c-raf antisense oligodeoxyribonucleotide infusion in combination with radiation therapy in patients with advanced malignancies.

Authors:  Anatoly Dritschilo; Chao H Huang; Charles M Rudin; John Marshall; Brian Collins; Jeanne L Dul; Chuanbo Zhang; Deepak Kumar; Prafulla C Gokhale; Ateeq Ahmad; Imran Ahmad; Jeffrey W Sherman; Usha N Kasid
Journal:  Clin Cancer Res       Date:  2006-02-15       Impact factor: 12.531

8.  Isolation of a novel mouse gene, mSVS-1/SUSD2, reversing tumorigenic phenotypes of cancer cells in vitro.

Authors:  Tetsuo Sugahara; Yzumi Yamashita; Masahito Shinomi; Banri Yamanoha; Hiroyoshi Iseki; Akihiko Takeda; Yasushi Okazaki; Yoshihide Hayashizaki; Kenji Kawai; Hiroshi Suemizu; Toshiwo Andoh
Journal:  Cancer Sci       Date:  2007-04-12       Impact factor: 6.716

9.  Analysis and update of the human solute carrier (SLC) gene superfamily.

Authors:  Lei He; Konstandinos Vasiliou; Daniel W Nebert
Journal:  Hum Genomics       Date:  2009-01       Impact factor: 4.639

10.  Differential gene expression profiles of radioresistant oesophageal cancer cell lines established by continuous fractionated irradiation.

Authors:  K Fukuda; C Sakakura; K Miyagawa; Y Kuriu; S Kin; Y Nakase; A Hagiwara; S Mitsufuji; Y Okazaki; Y Hayashizaki; H Yamagishi
Journal:  Br J Cancer       Date:  2004-10-18       Impact factor: 7.640

View more
  13 in total

1.  Overexpression of SLC7A7 predicts poor progression-free and overall survival in patients with glioblastoma.

Authors:  Songhua Fan; Delong Meng; Tao Xu; Yuanyuan Chen; Jingkun Wang; Xiaoying Li; Hongyan Chen; Daru Lu; Juxiang Chen; Qing Lan
Journal:  Med Oncol       Date:  2013-02-14       Impact factor: 3.064

2.  Ferroptosis as a mechanism to mediate p53 function in tumor radiosensitivity.

Authors:  Guang Lei; Yilei Zhang; Ting Hong; Xudong Zhang; Xiaoguang Liu; Chao Mao; Yuelong Yan; Pranavi Koppula; Weijie Cheng; Anil K Sood; Jinsong Liu; Boyi Gan
Journal:  Oncogene       Date:  2021-04-29       Impact factor: 9.867

Review 3.  Targeting ferroptosis as a vulnerability in cancer.

Authors:  Guang Lei; Li Zhuang; Boyi Gan
Journal:  Nat Rev Cancer       Date:  2022-03-25       Impact factor: 69.800

4.  mRNA and microRNA expression profiles of radioresistant NCI-H520 non-small cell lung cancer cells.

Authors:  Wei Guo; Li Xie; Long Zhao; Yuehuan Zhao
Journal:  Mol Med Rep       Date:  2015-04-08       Impact factor: 2.952

5.  Identification and Verification of Immune-Related Gene Prognostic Signature Based on ssGSEA for Osteosarcoma.

Authors:  Bo Xiao; Liyan Liu; Aoyu Li; Cheng Xiang; Pingxiao Wang; Hui Li; Tao Xiao
Journal:  Front Oncol       Date:  2020-12-15       Impact factor: 6.244

6.  Investigation of radiation-induced transcriptome profile of radioresistant non-small cell lung cancer A549 cells using RNA-seq.

Authors:  Hee Jung Yang; Namshin Kim; Ki Moon Seong; HyeSook Youn; BuHyun Youn
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

7.  Expression profiling of genes modulated by minocycline in a rat model of neuropathic pain.

Authors:  Ewelina Rojewska; Michal Korostynski; Ryszard Przewlocki; Barbara Przewlocka; Joanna Mika
Journal:  Mol Pain       Date:  2014-07-19       Impact factor: 3.395

8.  Sulfasalazine, an inhibitor of the cystine-glutamate antiporter, reduces DNA damage repair and enhances radiosensitivity in murine B16F10 melanoma.

Authors:  Masaki Nagane; Eiichi Kanai; Yuki Shibata; Takuto Shimizu; Chie Yoshioka; Takuya Maruo; Tadashi Yamashita
Journal:  PLoS One       Date:  2018-04-12       Impact factor: 3.240

9.  Arginine auxotrophic gene signature in paediatric sarcomas and brain tumours provides a viable target for arginine depletion therapies.

Authors:  Ashley Vardon; Madhumita Dandapani; Daryl Cheng; Paul Cheng; Carmela De Santo; Francis Mussai
Journal:  Oncotarget       Date:  2017-06-29

Review 10.  Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy.

Authors:  Pranavi Koppula; Li Zhuang; Boyi Gan
Journal:  Protein Cell       Date:  2020-10-01       Impact factor: 14.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.